🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06673121
Recruiting Observational

Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule

NCT06673121 · tracked via the Priya Life Science China tracker
Sponsor
Third Affiliated Hospital of Henan University of Traditional Chinese Medicine
Phase
Observational
Started
2024-01-03
Last updated
2024-11-04

Condition(s) studied

Pulmonary NoduleCohort StudyTraditional Chinese Medicine

Investigational drug(s) / intervention(s)

Traditional Chinese Medicine

Traditional Chinese Medicine: Received treatment with traditional Chinese medicine

Study summary

This study is a prospective multicenter cohort study that primarily evaluates the impact of traditional Chinese medicine treatment on pulmonary nodules

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: ① Patients with pulmonary nodules and recommended for follow-up by MDT; ② Voluntarily sign the informed consent form. Exclusion Criteria: ①Patients with metastatic pulmonary nodules; ②Patients with benign diseases such as pulmonary lymph nodes, hamartomas, sclerosing alveolar cell tumors, or nodules with obvious benign features such as calcification; ③Patients withserious heart, lung, liver and kidney diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine Zhengzhou Henan Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06673121 on ClinicalTrials.gov ↗ ← All trials in China